HSP Complete 15
Natural health product licensed in Canada
- Licence holder
- Prébionature Inc.
- NPN or DIN-HM
- 80145637
- Status
- Active licence
- Licence date
- 26 November 2025
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lactobacillus acidophilus Source : DDS-1 | 5 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : Lactobacillus acidophilus - Cellule entière | 5 Milliards d'UFC | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : BI-04 | 2 Milliards d'UFC | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : HN019 | 1.8 Milliards d'UFC | Not calculated |
| Lactococcus lactis Source : Lactococcus lactis - Cellule entière | 2 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : Lactobacillus acidophilus - Cellule entière | 1.2 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : La-14 | 1.2 Milliards d'UFC | Not calculated |
| Lacticaseibacillus rhamnosus Source : GG | 2 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : Bb-06 | 1 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : Bifidobacterium bifidum - Cellule entière | 1 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Poudre d'enveloppes d'Oryza sativa (Riz), Phosphate de potassium, monobasique, Phosphate de potassium, dibasique, Cellulose microcristalline, Sucrose, Hypromellose, Trehalose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Could promote a favorable gut flora. Helps support intestinal/gastrointestinal health. Promotes favourable gut flora/intestinal microflora. Reduces whole gut transit time/helps to accelerate intestinal transit time. Supports digestion by reducing transit time. Reduces frequency of functional gastrointestinal symptoms (e.g. constipation, irregularity, flatulence). Promotes bowel movement. Helps provide gentle relief of constipation and/or irregularity. Reduces the risk of developing upper-respiratory tract illness in physically active adults. Reduces the duration of upper-respiratory tract illness in physically active adults. May increase immune response time following oral vaccination.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80145637
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.